# A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults

> **NCT06965465** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 32 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-07999415
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06965465
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-08-22
- **Final completion:** 2026-08-22
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06965465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06965465, "A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06965465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*